Skip to Main Content
An official website of the United States government
Epidemiology and Genomics Research Program

Body Composition and Cancer Outcomes Research Webinar Series

The purpose of the Body Composition and Cancer Outcomes Research webinar series is to provide an opportunity for researchers and other interested individuals to share lessons learned, new methodologies, and new research integrating measures of body composition in cancer epidemiology research. This series is hosted by the Epidemiology and Genomics Research Program.

All interested individuals are invited to participate, however pre-registration is required. Each presentation will be about 30-40 minutes in length to allow for 20-30 minutes of discussion. Instructions for connecting to the webinars will be sent via e-mail to individuals who register.

Past Topics and Speakers

2022

Nov 17 2022

Fighting Fracture Risk in Cancer Survivors: Is Exercise Enough?

Kerri Winters-Stone, PhD, FACSMExternal Web Site Policy
Professor and Section Head, Cancer Population Sciences, Division of Oncological Sciences
Co-Program Leader, Cancer Prevention & Control
Co-Director, Community Partnership Program
Knight Cancer Institute
Oregon Health & Science University

View Webinar Description

Dr. Winters-Stone is an exercise scientist whose original work involved developing prescriptive exercise programs to prevent osteoporosis and fractures in people without cancer. In this seminar she gave an overview of how she has applied that work over the last 15 years to study whether exercise could be an effective countermeasure to fractures that are elevated from cancer treatment.

Fighting Fracture Risk in Cancer Survivors: Is Exercise Enough?

Sep 15 2022

Considerations for Body Composition in Ovarian Cancer Interventions and Analysis

Tracy E. Crane, PhD, RDNExternal Web Site Policy
Associate Professor, Medical Oncology, University of Miami Miller School of Medicine
Co-Lead, Cancer Control Research Program, Sylvester Comprehensive Cancer Center

Considerations for Body Composition in Ovarian Cancer Interventions and Analysis

Jul 21 2022

Skeletal Muscle Adaptations to Cancer and Its Treatment

Michael J. Toth, PhDExternal Web Site Policy
Professor and Vice Chair for Research
Department of Medicine
University of Vermont College of Medicine

View Webinar Description

Dr. Toth presented an overview of research examining the effects of cancer and its treatment on skeletal muscle size and function in humans, ranging from the whole body to the cellular level, and how maladaptations in skeletal muscle contribute to impaired physical functional capacity and quality of life. He also discussed the utility of exercise as an intervention to mitigate the detrimental effects of cancer and its treatment across the cancer continuum.

Skeletal Muscle Adaptations to Cancer and Its Treatment

Jun 16 2022

Body Composition Change in Pancreatic Cancer: Trajectory and Implications for Early Detection

Ana Babic, PhD, MSExternal Web Site Policy
Instructor in Medicine, Dana-Farber Cancer Center and Harvard Medical School

Michael H. Rosenthal, MD, PhD, FSARExternal Web Site Policy
Attending Radiologist, Dana-Farber Cancer Institute and Brigham and Women’s Hospital
Assistant Professor of Radiology, Harvard Medical School
Assistant Director for Radiology, DFBWCC Pancreaticobiliary Tumor Center

View Webinar Description

Dr. Babic described her work on early detection of pancreatic cancer using body composition analysis–specifically her work on changes in muscle and adipose tissue in years preceding diagnosis–and discussed how these changes can be leveraged as screening biomarkers of pancreatic cancer.

Dr. Rosenthal presented an overview of his research on body composition in pancreatic cancer. He discussed initial studies that suggested a link between muscle breakdown and early cancer and their subsequent evolution through mouse models and human studies. He also reviewed the role of AI-based automation in body composition analysis, how this approach was used to develop a reference cohort to normalize for demographic-related differences in body composition, and how demographic-adjusted body composition metrics can improve the power of body composition studies.

Body Composition Change in Pancreatic Cancer: Trajectory and Implications for Early Detection

May 19 2022

Adverse Body Composition Changes That Affect Cancer Survivors: Detection, Devising Interventions That Work, and Measuring Impact

Wendy Demark-Wahnefried, PhD, RDExternal Web Site Policy
Professor and Webb Endowed Chair of Nutrition Sciences, University of Alabama at Birmingham (UAB)
Associate Director of Cancer Prevention and Control, O'Neal Comprehensive Cancer Center at UAB

View Webinar Description

Dr. Demark-Wahnefried presented an overview of her research, ranging from observational studies that first documented sarcopenic obesity among cancer patients to diet, exercise, and weight management studies that improve body composition and result in improved outcomes among cancer survivors. She also discussed important questions surrounding communication with patients and the translation of research to clinical care and scalable interventions within the community.

Adverse Body Composition Changes That Affect Cancer Survivors: Detection, Devising Interventions That Work, and Measuring Impact

Apr 21 2022

Sarcopenia and Treatment Tolerability in Older Patients with Advanced Cancer

Supriya G. Mohile, MD, MS
Philip and Marilyn Wehrheim Professor of Medicine and Surgery
Director, Geriatric Oncology Research
Co-Program Leader, Cancer Prevention and Control Program
Wilmot Cancer Institute

Richard F. Dunne, MD, MS
Assistant Professor of Medicine
Leader, Gastrointestinal Cancer Unit and Clinical Research
Wilmot Cancer Institute
University of Rochester Medical Center

View Webinar Description

Drs. Mohile and Dunne discussed their work examining the relationship between body composition and anti-cancer treatment tolerability in older adults with cancer.

Sarcopenia and Treatment Tolerability in Older Patients with Advanced Cancer

Mar 17 2022

Energy Balance in Colorectal Cancer: From Body Composition to Adipose-tumor Interactions

Jennifer Ose, PhD, MSExternal Web Site Policy
Research Assistant Professor
Department of Population Health Sciences and Huntsman Cancer Institute
University of Utah

Cornelia M. Ulrich, PhD, MSExternal Web Site Policy
Chief Scientific Officer and Executive Director, Comprehensive Cancer Center, Huntsman Cancer Institute
Jon M. and Karen Huntsman Presidential Professor in Cancer Research, Department of Population Health Sciences, University of Utah

View Webinar Description

Drs. Ulrich and Ose presented their work from the ColoCare Study using body composition measures to understand colorectal cancer biology and clinical outcomes. They discussed their findings for CT-derived measures of body composition, biomarkers of angiogenesis and inflammation, as well as direct adipose tissue-tumor interaction.

Energy Balance in Colorectal Cancer: From Body Composition to Adipose-tumor Interactions

Feb 17 2022

Targeting Adipose Inflammation to Improve Breast Cancer Outcomes

Neil M. Iyengar, MDExternal Web Site Policy
Associate Member & Attending Physician
Breast Medicine Service, Evelyn H. Lauder Breast and Imaging Center
Memorial Sloan Kettering Cancer Center

View Webinar Description

Dr. Iyengar presented his group’s research investigating the impact of adipose tissue biology on cancer progression. He discussed how adiposity alters the tumor microenvironment and ongoing intervention trials that seek to reduce adiposity, optimize body composition, and improve breast cancer outcomes.

Targeting Adipose Inflammation to Improve Breast Cancer Outcomes

Jan 20 2022

New Insights into Clinical Importance and Genetics of Body Fat Distribution

Saaket Agrawal
Broad Institute

View Webinar Description

In this webinar, Saaket Agrawal discussed his work utilizing MRI-derived measurements of adiposity to understand disease associations and the genetic architecture of body fat distribution. He also discussed how an individual's outline can be used to estimate these adiposity measurements to provide disease prediction information independent of body mass index and waist circumference.

New Insights into Clinical Importance and Genetics of Body Fat Distribution

2021

Apr 15 2021

Body Composition in Cancer Epidemiology: Assessment, Associations and Future Directions

Elizabeth Feliciano, ScD, MScExternal Web Site Policy
Kaiser Permanente Northern California

View Webinar Description

Dr. Feliciano presented an overview of her research examining body composition as an important risk factor for short- and long-term outcomes after a cancer diagnosis. She also discussed important questions surrounding this issue, including the biologic mechanisms that underlie these relationships, developing safe and accurate measures of body composition for use in the clinic, and how patient body composition is most relevant to clinical care.

Body Composition in Cancer Epidemiology: Assessment, Associations and Future Directions

Mar 11 2021

Defining and Managing Cachexia at the Individual Level

Marcus DaSilva Goncalves, MD, PhDExternal Web Site Policy
Weill Cornell Medical College

View Webinar Description

Dr. Goncalves presented an overview of his clinical work assessing and managing cachexia in cancer patients. He used specific case examples and retrospective data to highlight potential weight management strategies.

Defining and Managing Cachexia at the Individual Level

Feb 11 2021

Body Composition and Treatment-Related Toxicities

Michael Sawyer, MD, BSc PharmacyExternal Web Site Policy
Medical Oncologist and Clinical Pharmacologist, Cross Cancer Institute
Professor, Department of Oncology, Division of Medical Oncology, University of Alberta

View Webinar Description

Dr. Sawyer presented an overview of research describing how body composition contributes to treatment-related toxicities in cancer patients. Implications for drug dosing and metabolism were discussed.

Body Composition and Treatment-Related Toxicities

Jan 14 2021

Investigating the BMI Paradox in Kidney Cancer

Helena Furberg, MSPH, PhDExternal Web Site Policy
Memorial Sloan Kettering Cancer Center

View Webinar Description

Dr. Furberg discussed the body mass index (BMI) paradox in kidney cancer- where patients who have high BMI at diagnosis survive longer than patients who are classified as normal weight. She highlighted the research her group is doing related to the molecular underpinnings of this association and also described the RESOLVE Study which refines BMI into body composition features and transcriptomically profiles tumors from more than 1,000 kidney cancer patients treated at Memorial Sloan Kettering Cancer Center to more accurately identify patients at highest mortality risk.

Investigating the BMI Paradox in Kidney Cancer

2020

Dec 17 2020

Automating Body Composition from Routinely Acquired CT images-towards 3D measurements

Mirza Faisal Beg, PhD, PEngExternal Web Site Policy
Simon Fraser University

View Webinar Description

Dr. Beg presented recent developments in automating body composition measurements from CT scans and discussed applications for research.

Automating Body Composition from Routinely Acquired CT images-towards 3D measurements

Nov 12 2020

Sarcopenia and Cancer Survival: Findings, Gaps, and Future Research

Bette J. Caan, DrPHExternal Web Site Policy
Senior Research Scientist and Nutritional Epidemiologist
Kaiser Permanente Northern California, Division of Research

View Webinar Description

Dr. Caan presented an overview of the work to date on sarcopenia (loss of skeletal muscle mass and/or function) and cancer outcomes. She discussed methodological challenges and existing research gaps and identify future directions.

Sarcopenia and Cancer Survival: Findings, Gaps, and Future Research

Previous Body Composition and Cancer Webinar Series

A previous series of webinars, hosted by Dr. Bette Caan of Kaiser Permanente Northern California Division of Research, was held from 2018-2020.

  • 06/18/2020
    Andrew Dannenberg, MD, MPH
    - “Measurement of adipose inflammation and its relationship to body composition.”
  • 05/21/2020
    Peggy Cawthon, PhD, MPH
    - “The new sarcopenia definition and outcomes consortium definitions of sarcopenia in aging: How can we adapt them to be used for cancer patients?”
  • 04/16/2020
    Michael Rosenthal, MD, PhD
    - “Automated measurement of body composition in cancer patients: a radiologist perspective on integrating into clinical care.”
  • 02/20/2020
    Kristin Campbell, PhD
    - “Maintaining muscle health with exercise in cancer survivors: when and how to intervene.”
  • 01/16/2020
    Jose Garcia, PhD
    - “The biology of muscle loss in cancer and current therapeutic trials for the treatment of muscle loss.”
  • 12/19/2019
    Patrick Bradshaw, PhD
    - “Optimal stratification cutpoints for definition of sarcopenia and other body composition measures: When is it appropriate and when is it not?”
  • 11/21/2019
    Maria Cristina Gonzalez, MD, PhD
    - “The use of bioelectrical impedance analysis (and phase angle) in cancer research.”
  • 10/17/2019
    Stewart Wang, MD, PhD
    - “Normative values for body composition from multiple non-cancer populations.”
  • 09/26/2019
    Carla Prado, PhD
    - “Building muscle mass with targeted nutrition supplementation.”
  • 05/09/2019
    Karteek Popuri, PhD
    - “Automatic image segmentation for Body Composition Analysis”
  • 04/11/2019
    Bill Evans, PhD
    - “Use of D3-creatine dilution to measure muscle mass”
  • 03/14/2019
    Brian Wolpin, MD
    - “Altered systemic metabolism as a marker of early pancreatic cancer”
  • 02/14/2019
    Steven Heymsfield, MD
    - “11th International SCWD conference on cachexia, sarcopenia and muscle wasting”
  • 01/10/2019
    Marina Mourtzakis, PhD
    - “Methodological considerations for measuring muscle and fat quantity and quality using computed tomography and ultrasound.”
  • 11/08/2018
    Vickie Baracos, PhD
    - “Chemotoxicity in cancer: the sarcopenic obese patient.”

Contact Us

We welcome questions about individual webinars or the series.

Contact the Planning Committee